Latest Ratios: P/E Ratio 35.6x · EV/EBITDA 14.3x · ROE 27.2%. (2002–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $4.3B | $3.1B | $4.8B | $2.1B | $1.0B | $1.9B | $2.0B | $3.9B | $4.2B | $4.0B | $4.4B |
| Enterprise Value | $7.8B | $6.6B | $7.2B | $4.8B | $4.1B | $5.1B | $5.3B | $6.8B | $5.8B | $5.3B | $5.9B |
| P/E Ratio → | 35.56 | 22.35 | 15.04 | 10.51 | — | — | — | 20.77 | 19.56 | 15.41 | 17.52 |
| P/S Ratio | 1.39 | 1.00 | 1.57 | 0.70 | 0.42 | 1.25 | 2.96 | 1.20 | 1.30 | 1.35 | 1.52 |
| P/B Ratio | 12.00 | 7.54 | 7.95 | 6.72 | 8.57 | 5.65 | 2.54 | 2.73 | 2.85 | 2.85 | 3.49 |
| P/FCF | 24.37 | 17.61 | 15.22 | 7.26 | 40.46 | 26.73 | — | 15.28 | 19.84 | 27.38 | 35.55 |
| P/OCF | 10.90 | 7.88 | 10.30 | 4.82 | 7.53 | 11.37 | — | 7.02 | 7.51 | 7.65 | 9.83 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.11 | 2.36 | 1.58 | 1.68 | 3.39 | 7.73 | 2.08 | 1.80 | 1.77 | 2.03 |
| EV / EBITDA | 14.27 | 12.06 | 12.93 | 8.34 | 27.80 | 397.51 | — | 11.40 | 8.93 | 8.43 | 9.37 |
| EV / EBIT | 22.70 | 20.66 | 17.19 | 12.29 | — | — | — | 16.99 | 13.16 | 11.76 | 12.63 |
| EV / FCF | — | 37.02 | 22.84 | 16.44 | 163.09 | 72.53 | — | 26.45 | 27.49 | 35.95 | 47.42 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 18.6% | 18.6% | 64.4% | 18.6% | 64.4% | 66.0% | 65.7% | 63.1% | 63.4% | 62.1% | 61.7% |
| Operating Margin | 11.0% | 11.0% | 11.8% | 12.1% | -3.7% | -16.7% | -110.0% | 10.3% | 12.1% | 13.1% | 14.5% |
| Net Profit Margin | 4.4% | 4.4% | 10.2% | 6.1% | -11.0% | -28.0% | -89.9% | 5.8% | 6.6% | 8.8% | 8.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 27.2% | 27.2% | 67.2% | 85.9% | -119.5% | -74.6% | -54.9% | 13.1% | 14.8% | 19.6% | 21.4% |
| ROA | 2.9% | 2.9% | 6.3% | 3.9% | -5.4% | -7.8% | -10.8% | 3.7% | 4.8% | 6.0% | 6.0% |
| ROIC | 7.5% | 7.5% | 8.9% | 8.9% | -2.0% | -5.0% | -13.5% | 6.8% | 10.1% | 10.8% | 12.0% |
| ROCE | 9.3% | 9.3% | 9.1% | 9.1% | -2.1% | -5.4% | -15.0% | 7.4% | 9.7% | 10.0% | 11.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 9.14 | 9.14 | 5.73 | 11.14 | 31.61 | 11.79 | 4.92 | 2.33 | 1.39 | 1.26 | 1.61 |
| Debt / EBITDA | 6.96 | 6.96 | 6.21 | 6.11 | 25.45 | 305.82 | — | 5.63 | 3.14 | 2.84 | 3.23 |
| Net Debt / Equity | — | 8.31 | 3.98 | 8.48 | 25.96 | 9.68 | 4.10 | 1.99 | 1.10 | 0.89 | 1.16 |
| Net Debt / EBITDA | 6.32 | 6.32 | 4.31 | 4.65 | 20.91 | 250.99 | — | 4.82 | 2.48 | 2.01 | 2.35 |
| Debt / FCF | — | 19.40 | 7.61 | 9.17 | 122.63 | 45.80 | — | 11.17 | 7.65 | 8.57 | 11.87 |
| Interest Coverage | 1.94 | 1.94 | 2.52 | 2.28 | -0.48 | -1.53 | -5.04 | 3.13 | 3.40 | 4.26 | 4.33 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.71 | 0.71 | 1.01 | 1.45 | 1.22 | 1.14 | 1.47 | 0.90 | 1.18 | 1.11 | 1.53 |
| Quick Ratio | 0.67 | 0.67 | 0.99 | 1.42 | 1.19 | 1.12 | 1.45 | 0.87 | 1.14 | 1.08 | 1.49 |
| Cash Ratio | 0.41 | 0.41 | 0.82 | 1.16 | 0.95 | 0.92 | 1.08 | 0.69 | 0.90 | 1.11 | 1.27 |
| Asset Turnover | — | 0.70 | 0.60 | 0.63 | 0.51 | 0.29 | 0.12 | 0.56 | 0.72 | 0.67 | 0.68 |
| Inventory Turnover | 87.19 | 87.19 | 35.00 | 107.13 | 36.86 | 33.09 | 18.69 | 55.81 | 61.12 | 64.71 | 65.86 |
| Days Sales Outstanding | — | 20.85 | 19.31 | 16.32 | 17.06 | 27.89 | 101.27 | 9.76 | 11.14 | 12.32 | 10.30 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.8% | 1.2% | — | — | — | — | 2.1% | 4.0% | 3.6% | 3.3% | 2.8% |
| Payout Ratio | 28.1% | 28.1% | — | — | — | — | — | 83.2% | 69.9% | 51.1% | 49.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.8% | 4.5% | 6.6% | 9.5% | — | — | — | 4.8% | 5.1% | 6.5% | 5.7% |
| FCF Yield | 4.1% | 5.7% | 6.6% | 13.8% | 2.5% | 3.7% | — | 6.5% | 5.0% | 3.7% | 2.8% |
| Buyback Yield | 6.4% | 8.8% | 0.1% | 0.1% | 0.4% | 0.2% | 0.3% | 0.1% | 0.1% | 0.1% | 0.2% |
| Total Shareholder Yield | 7.2% | 10.1% | 0.1% | 0.1% | 0.4% | 0.2% | 2.3% | 4.1% | 3.6% | 3.4% | 3.0% |
| Shares Outstanding | — | $134M | $155M | $152M | $118M | $117M | $117M | $117M | $117M | $116M | $116M |
Includes 30+ ratios · 23 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CNK stock.
Cinemark Holdings, Inc.'s current P/E ratio is 35.6x. The historical average is 18.0x. This places it at the 100th percentile of its historical range.
Cinemark Holdings, Inc.'s current EV/EBITDA is 14.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 10.4x.
Cinemark Holdings, Inc.'s return on equity (ROE) is 27.2%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 13.7%.
Based on historical data, Cinemark Holdings, Inc. is trading at a P/E of 35.6x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Cinemark Holdings, Inc.'s current dividend yield is 0.78% with a payout ratio of 28.1%.
Cinemark Holdings, Inc. has 18.6% gross margin and 11.0% operating margin. Operating margin between 10-20% is typical for established companies.
Cinemark Holdings, Inc.'s Debt/EBITDA ratio is 7.0x, indicating high leverage. A ratio above 4x may signal elevated financial risk.
Key Metrics
Top Statement Risk
High leverage and FX volatility
Metrics are mathematically derived from official filings.
Margin Volatility Masks Underlying Strength
Q2 2026 gross margin hit 51.3%, up from 21.0% in Q1, while operating margin expanded to 21.4%, reflecting a record release slate and concession mix, per quarterly filings.
The dramatic swing in gross margin between quarters underscores the lumpy nature of film rental costs, which scale with box office performance. The 21.4% operating margin in Q2 2026, versus 3.7% in Q1, suggests significant operating leverage when attendance peaks. However, the trailing twelve-month net margin of 12.8% is distorted by the record quarter; investors should focus on normalized margins across a full content cycle, as the prior year's Q1 posted a -7.2% net margin.
ROIC Recovery Still Below Pre-Pandemic Peaks
ROIC reached 6.3% in Q2 2026, up from 0.6% in Q1, but remains below the 39.8% ROE seen in Q3 2024, indicating a still-recovering capital base, as reported.
The 6.3% ROIC in Q2 2026 is a marked improvement from the 0.4% in Q1 2024, but it remains modest relative to the cost of capital, given the high leverage. The elevated ROE of 27.2% (TTM) is amplified by a debt-to-equity ratio that, while down to 0.92 in Q2 2026 from 9.14 in Q4 2025, still indicates a leveraged equity base. The improvement in ROIC appears driven by margin expansion rather than asset turnover, which has stayed flat around 0.20, suggesting the company is not yet efficiently utilizing its fixed asset base.
Negative CCC Reflects Supplier Financing Strength
Cash conversion cycle improved to -79 days in Q2 2026, driven by DPO of 103 days, indicating Cinemark is using supplier credit to fund operations, per latest data.
The negative CCC, which has been consistently negative over the past ten quarters, suggests Cinemark enjoys favorable payment terms with film distributors and concession suppliers, effectively financing its working capital needs. DPO of 103 days in Q2 2026, up from 81 days in Q4 2025, indicates increasing supplier leverage, though this may not be sustainable if distributors tighten terms. The DSO of 18 days is stable, reflecting the cash nature of ticket and concession sales, while DIO of 6 days is minimal, underscoring the perishable nature of concession inventory.
Leverage Drops but Debt Service Remains a Watch Item
Debt-to-equity fell to 0.92 in Q2 2026 from 9.14 in Q4 2025, while interest coverage improved to 7.49x, yet absolute debt of $1.9B remains substantial, per balance sheet.
The dramatic deleveraging in Q2 2026, with equity surging to $2.1B from $381M in Q1, appears driven by retained earnings and possibly asset revaluations, but the absolute debt level remains high. Interest coverage of 7.49x in Q2 2026 is a significant improvement from 0.64x in Q1, but it is still below the 4.47x seen in Q3 2024, indicating that debt service is comfortable only during peak quarters. The D/EBITDA of 6.71x in Q2 2026, down from 30.73x in Q4 2025, suggests that the market's forward EV/EBITDA of 6.09x implies a normalization of earnings, which may not materialize if box office volumes decline.
Current Ratio Below 1 Signals Short-Term Pressure
Current ratio improved to 0.78 in Q2 2026 from 0.62 in Q1, but remains below 1.0, indicating current liabilities exceed current assets, as per latest balance sheet.
Despite the improvement, the current ratio of 0.78 suggests that Cinemark may face short-term liquidity constraints if it cannot roll over its obligations. The quick ratio of 0.74, which excludes inventory, is only slightly lower, indicating that inventory is not a significant buffer. The company's cash position of $504M provides some cushion, but the reliance on operating cash flow to meet near-term obligations is evident. Investors should monitor whether the company can maintain positive working capital trends, especially during seasonally weak quarters like Q1.
P/E Misleads in Cyclical Business
The trailing P/E of 35.19 is distorted by a record quarter, while forward P/E of 15.85 better reflects normalized earnings, but EV/EBITDA of 14.19 may overstate value, per data.
The most commonly misapplied ratio for Cinemark is the P/E, given the extreme cyclicality of box office revenues. The trailing P/E of 35.19 is artificially low due to the Q2 2026 earnings spike, while the forward P/E of 15.85 assumes a sustained recovery that may not hold. A more appropriate metric is EV/EBITDA, which at 14.19 (trailing) and 6.09 (forward) better captures the company's operating performance and leverage. However, even EV/EBITDA can be misleading if EBITDA is not adjusted for the high fixed-cost base and potential impairments; investors should use a mid-cycle EBITDA estimate to assess valuation.